Xenetic Biosciences, Inc. financial data

Symbol
XBIO on Nasdaq
Location
945 Concord St., Framingham, MA
State of incorporation
Nevada
Fiscal year end
December 31
Former names
General Sales & Leasing, Inc. (to 1/10/2014), GENERAL AIRCRAFT INC. (to 2/12/2013)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 890 % -35%
Debt-to-equity 11.4 % +56%
Return On Equity -51 % -60.9%
Return On Assets -45.8 % -55%
Operating Margin -199 % +5.22%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.54M shares +0.62%
Common Stock, Shares, Outstanding 1.54M shares +0.56%
Entity Public Float 5.03M USD -55.6%
Common Stock, Value, Issued 1.54K USD +0.52%
Weighted Average Number of Shares Outstanding, Basic 1.54M shares +1.06%
Weighted Average Number of Shares Outstanding, Diluted 1.54M shares +1.06%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.52M USD +16.8%
Research and Development Expense 3.87M USD +25.4%
General and Administrative Expense 3.65M USD +1.73%
Operating Income (Loss) -5.01M USD -10.7%
Nonoperating Income (Expense) 312K USD -5.57%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -4.7M USD -12%
Earnings Per Share, Basic -3.07 USD/shares +20.1%
Earnings Per Share, Diluted -3.07 USD/shares +20.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 8.01M USD -33.5%
Property, Plant and Equipment, Net 0 USD
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 1.02M USD +44.6%
Assets 9.03M USD -29.1%
Accounts Payable, Current 284K USD +28.2%
Employee-related Liabilities, Current 217K USD -38.7%
Accrued Liabilities, Current 569K USD -27.6%
Liabilities, Current 1.59M USD +82.2%
Operating Lease, Liability, Noncurrent 0 USD
Liabilities 1.59M USD +82.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 254K USD 0%
Retained Earnings (Accumulated Deficit) -196M USD -2.46%
Stockholders' Equity Attributable to Parent 7.45M USD -37.3%
Liabilities and Equity 9.03M USD -29.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.16M USD -5.16%
Common Stock, Shares Authorized 10M shares 0%
Common Stock, Shares, Issued 1.54M shares +0.55%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.3M USD -32%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 40.4M USD +3.59%
Deferred Tax Assets, Gross 39.7M USD +2.95%
Property, Plant and Equipment, Gross 0 USD -100%
Operating Lease, Liability, Current 0 USD -100%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 208M USD +0.13%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 300K USD -40%